165 related articles for article (PubMed ID: 23811564)
1. In vivo pharmacokinetics and pharmacodynamics of positional isomers of mono-PEGylated recombinant human granulocyte colony stimulating factor in rats.
Kang JS; Lee KC
Biol Pharm Bull; 2013; 36(7):1146-51. PubMed ID: 23811564
[TBL] [Abstract][Full Text] [Related]
2. Structural identification and biological activity of positional isomers of long-acting and mono-PEGylated recombinant human granulocyte colony-stimulating factor with trimeric-structured methoxy polyethylene glycol N-hydroxysuccinimidyl functional group.
Son JP; Jun SW; Choi YK; Park HS; Son MK; Lee MY; Kang SH; Kang JS; Park YI
Anal Biochem; 2012 Apr; 423(2):286-93. PubMed ID: 22244804
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and Pharmacodynamics of Two Formulations of Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor in Healthy Chinese Subjects: An Open-Label, Randomized, Parallel-Design Bioavailability Study.
Hu C; Ji B; Hu X; Yang C; Sun W; Zhao X; Li L; Li X; Zhang L
Clin Pharmacol Drug Dev; 2021 Mar; 10(3):291-298. PubMed ID: 32567217
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic/pharmacodynamic analysis of neutrophil proliferation induced by recombinant granulocyte colony-stimulating factor (rhG-CSF): comparison between intravenous and subcutaneous administration.
Sugiura M; Yamamoto K; Sawada Y; Iga T
Biol Pharm Bull; 1997 Jun; 20(6):684-9. PubMed ID: 9212991
[TBL] [Abstract][Full Text] [Related]
5. Relationship between absolute neutrophil count profiles and pharmacokinetics of DA-3031, a pegylated granulocyte colony-stimulating factor (pegylated-G-CSF): a dose block-randomized, double-blind, dose-escalation study in healthy subjects.
Ahn LY; Shin KH; Lim KS; Kim TE; Jeon H; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Drug Investig; 2013 Nov; 33(11):817-24. PubMed ID: 24078278
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study].
Shi YK; He XH; Yang S; Wang HQ; Jiang ZF; Zhu YZ; Ke XY; Zhang Y; Liu YP; Zhang WJ; Wang Z; Shi QZ; Xie XD; Zhang HL; Wang JJ; Luo DY; Zheng QS; Sun RY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3414-9. PubMed ID: 17313855
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor conjugated to polyethylene glycol in rats.
Tanaka H; Satake-Ishikawa R; Ishikawa M; Matsuki S; Asano K
Cancer Res; 1991 Jul; 51(14):3710-4. PubMed ID: 1712246
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic study of a novel recombinant human granulocyte colony-stimulating factor in rats.
Liu XX; Jiang YP
Chin Med Sci J; 2010 Mar; 25(1):13-9. PubMed ID: 20449948
[TBL] [Abstract][Full Text] [Related]
9. Prolonged circulation of recombinant human granulocyte-colony stimulating factor by covalent linkage to albumin through a heterobifunctional polyethylene glycol.
Paige AG; Whitcomb KL; Liu J; Kinstler O
Pharm Res; 1995 Dec; 12(12):1883-8. PubMed ID: 8786961
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of intravenous recombinant human granulocyte colony-stimulating factor (rhG-CSF) in children receiving myelosuppressive cancer chemotherapy: clearance increases in relation to absolute neutrophil count with repeated dosing.
Sturgill MG; Huhn RD; Drachtman RA; Ettinger AG; Ettinger LJ
Am J Hematol; 1997 Feb; 54(2):124-30. PubMed ID: 9034286
[TBL] [Abstract][Full Text] [Related]
11. Enhanced circulation half-life of site-specific PEGylated rhG-CSF: optimization of PEG molecular weight.
Zhai Y; Zhao Y; Lei J; Su Z; Ma G
J Biotechnol; 2009 Jul; 142(3-4):259-66. PubMed ID: 19497340
[TBL] [Abstract][Full Text] [Related]
12. [Phase I clinical trail of intravenous pegylated recombinant human granulocyte colony-stimulating factor].
Shi YK; Liu P; Yang S; Han XH; He XH; Ai B; Qin Y; Li B; Huang DZ; Zhang CG; Sun Y
Ai Zheng; 2006 Apr; 25(4):495-500. PubMed ID: 16613688
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of two recombinant human granulocyte colony-stimulating factor glycoforms. Pharmacokinetic and activity studies of single-dose administration in mice.
Rotondaro L; De Paolis E; Ferrero D; D'Alatri L; Raucci G; Fabbri A; Gerwig GJ; Kamerling JP; Mariani MF; Mele A; De Santis R
Mol Biotechnol; 1999 Apr; 11(2):117-28. PubMed ID: 10464766
[TBL] [Abstract][Full Text] [Related]
14. Absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) from rat nasal mucosa.
Machida M; Sano K; Arakawa M; Hayashi M; Awazu S
Pharm Res; 1993 Sep; 10(9):1372-7. PubMed ID: 7694272
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic modelling of the novel human granulocyte colony-stimulating factor derivative Maxy-G34 and pegfilgrastim in rats.
Scholz M; Engel C; Apt D; Sankar SL; Goldstein E; Loeffler M
Cell Prolif; 2009 Dec; 42(6):823-37. PubMed ID: 19780759
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat. Single and multiple dosing studies.
Tanaka H; Kaneko T
Drug Metab Dispos; 1991; 19(1):200-4. PubMed ID: 1708329
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetics and pharmacodynamics of pegylated recombinant human granulocyte colony-stimulating factor in children with acute lymphoblastic leukemia: a prospective control trial].
Yang WY; Liu TF; Chen XJ; Guo Y; Li T; Qi BQ; Liu F; Chang LX; Ruan M; Liu XM; Zhang L; Zou Y; Chen YM; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Nov; 22(11):1172-1177. PubMed ID: 33172550
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim.
van Der Auwera P; Platzer E; Xu ZX; Schulz R; Feugeas O; Capdeville R; Edwards DJ
Am J Hematol; 2001 Apr; 66(4):245-51. PubMed ID: 11279634
[TBL] [Abstract][Full Text] [Related]
19. Sex differences in the pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat.
Tanaka H; Kaneko T
Drug Metab Dispos; 1991; 19(6):1034-9. PubMed ID: 1724959
[TBL] [Abstract][Full Text] [Related]
20. The effects and pharmacokinetics of rhG-CSF in patients with chronic renal failure.
Akizawa T; Shishido K; Koshikawa S
Artif Organs; 1995 Dec; 19(12):1251-7. PubMed ID: 8967884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
